3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
42
Neoplasms
6
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Adenocarcinoma
3
Resectable Pancreatic Cancer
2
Rectal Neoplasms
2
Pancreatic Cancer Metastatic
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urachal cancer
1
Stomach Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Cancer Non-resectable
1
Pancreatic Adenocarcinoma
1
Neoplasms, Basal Cell
1
Locally Advanced Unresectable or Metastatic Solid Tumors
1
Localized Pancreatic Adenocarcinoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Islet Cell
1
Carcinoma
1
Borderline Resectable Pancreatic Cancer
1
Interventions
pembrolizumab
1
folfirinox
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Localized Pancreatic Adenocarcinoma
×
folfirinox
×
Clear all
NCT06384560
2026-02-13
PREOPANC-5
Amsterdam UMC, location VUmc
Phase 1/2
Recruiting
66 enrolled